Linklaters, Hogan Lovells Lead Ingredion’s £2.7bn Tate & Lyle Buy

Why It Matters

The merger creates the world’s largest ingredient‑solutions group while accelerating the drift of high‑profile UK companies away from the London Stock Exchange, reshaping market depth and valuation dynamics.

Key Takeaways

• Ingredion pays £2.7bn cash, ≈$3.4bn, for Tate & Lyle.
• Tate & Lyle shareholders receive 595p + 20p dividend, 59% premium.
• Combined firm targets $9.9bn revenue, $1.8bn adjusted profit.
• Deal ends Tate & Lyle’s 87‑year London listing, valued £3.8bn (~$4.8bn).
• London market loses another FTSE 250 member amid delisting surge.

Pulse Analysis

The U.S.-based food‑ingredients giant Ingredion has agreed to acquire Britain’s Tate & Lyle in a cash transaction valued at £2.7 billion, roughly $3.4 billion. London law firms Linklaters and Hogan Lovells were appointed as lead advisers for the seller and buyer respectively, underscoring the deal’s complexity. Tate & Lyle shareholders will be paid 595 pence per share plus a 20‑pence dividend, representing a 59 percent premium to the pre‑announcement price. Including debt, the total enterprise value reaches about £3.8 billion (≈$4.8 billion), and the transaction is slated to close in the second half of 2027.

The merger creates a combined ingredient solutions powerhouse with projected annual revenue of $9.9 billion and adjusted earnings of $1.8 billion. Ingredion’s portfolio of sweeteners, starches and specialty ingredients dovetails with Tate & Lyle’s expertise in artificial sweeteners and specialty food components, giving the new entity broader geographic reach and a more diversified product mix. Industry analysts see the scale‑up as a response to rising demand for healthier, low‑calorie and plant‑based foods, positioning the group to capture growth in both consumer and industrial segments.

Beyond the strategic fit, the deal highlights a continuing exodus of high‑profile companies from the London Stock Exchange. Tate & Lyle’s 87‑year listing will end, adding to a 2024 tally of over 150 firms that have delisted or shifted primary listings to the United States in search of higher valuations and deeper liquidity. The departure erodes the FTSE’s depth, pressures market confidence, and may accelerate further cross‑border M&A activity as U.S. investors seek exposure to European food‑ingredients assets. Regulators are now weighing incentives to retain marquee issuers.